Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Interleukin-6 deficiency exacerbates Huntington’s disease model phenotypes

Interleukin-6 deficiency exacerbates Huntington’s disease model phenotypes

Thumbnail Image
Download
Name

13024_2020_Article_379.pdf

Size

1.43 MB

Format

Adobe PDF

Checksum (MD5)

eaf440829e7a2ae2b7065043c8e272e9

Download all files submitted through automated deposit
art_7942093293612652039.zip (1.15 MB)
Author(s)
Wertz, Mary H.
•
Pineda, S. Sebastian
•
Lee, Hyeseung
•
Kulicke, Ruth
•
Kellis, Manolis
•
Heiman, Myriam
Date Issued
May 24, 2020
Journal
Molecular Neurodegeneration
Publisher
BioMed Central
Citation
Wertz, Mary H. et al. "Interleukin-6 deficiency exacerbates Huntington’s disease model phenotypes." Molecular Neurodegeneration 15 (May 2020): no. 29 doi 10.1186/s13024-020-00379-3 ©2020 Author(s)
Version
Final published version
Abstract
Huntington’s disease (HD) is an incurable neurodegenerative disorder caused by CAG trinucleotide expansions in the huntingtin gene. Markers of both systemic and CNS immune activation and inflammation have been widely noted in HD and mouse models of HD. In particular, elevation of the pro-inflammatory cytokine interleukin-6 (IL-6) is the earliest reported marker of immune activation in HD, and this elevation has been suggested to contribute to HD pathogenesis. To test the hypothesis that IL-6 deficiency would be protective against the effects of mutant huntingtin, we generated R6/2 HD model mice that lacked IL-6. Contrary to our prediction, IL-6 deficiency exacerbated HD-model associated behavioral phenotypes. Single nuclear RNA Sequencing (snRNA-seq) analysis of striatal cell types revealed that IL-6 deficiency led to the dysregulation of various genes associated with synaptic function, as well as the BDNF receptor Ntrk2. These data suggest that IL-6 deficiency exacerbates the effects of mutant huntingtin through dysregulation of genes of known relevance to HD pathobiology in striatal neurons, and further suggest that modulation of IL-6 to a level that promotes proper regulation of genes associated with synaptic function may hold promise as an HD therapeutic target.
MIT Department
Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences
Picower Institute for Learning and Memory
Broad Institute of MIT and Harvard
Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory
Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science
Terms of Use
Creative Commons Attribution
https://creativecommons.org/licenses/by/4.0/
Persistent DSpace Link
https://hdl.handle.net/1721.1/126311
DOI of Published Version
https://doi.org/10.1186/s13024-020-00379-3
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.